fr
Article scientifique
Anglais

Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort

Publié dansAlimentary pharmacology & therapeutics, no. 8, p. 1007-1016
Date de publication2010
Résumé

BACKGROUND: About 30-50% of patients with Crohn's disease (CD) develop fistulae, implying significant disease burden and complicated clinical management. AIM: To assess appropriate use of therapy for fistulizing CD patients enrolled in the Swiss Inflammatory Bowel Disease Cohort using criteria developed by the European Panel on the Appropriateness of Crohn's disease Therapy. METHODS: Specific questionnaires were used to gather information on disease and its management. We assessed appropriateness of therapy at enrolment for adult CD patients with one or several fistulae. RESULTS: Two hundred and eighty-eight CD patients had fistulizing disease, of which 80% had complex fistulae and 32% currently had active draining fistulae. Mean age (s.d.) at diagnosis was 27 years (11), 51% males. Of the patients, 78% were judged as having globally an appropriate therapy, which was more often given for complex fistulae (87%) than for simple fistulae (67%). Antibiotics, azathioprine/MP, methotrexate and conservative surgery were almost always appropriate. Anti-tumor necrosis factor alpha was considered globally appropriate (91%), although most often with an uncertain indication. The 5ASA compounds, steroids and aggressive surgery were most often inappropriate (84%, 58% and 86% respectively). CONCLUSIONS: Formal appropriateness criteria for CD therapy were applied to a national cohort of IBD patients. For more than three-quarters of the patients with fistulizing CD, therapy was globally appropriate.

Mots-clés
  • Adult
  • Antibodies, Monoclonal/therapeutic use
  • Cohort Studies
  • Crohn Disease/*complications/drug therapy/surgery/*therapy
  • Cross-Sectional Studies
  • Female
  • Fistula/*therapy
  • Gastrointestinal Agents/therapeutic use
  • Humans
  • Immunosuppressive Agents/therapeutic use
  • Male
  • Middle Aged
  • Quality Assurance, Health Care/methods
  • Tumor Necrosis Factor-alpha/therapeutic use
  • Young Adult
Citation (format ISO)
PITTET, V. et al. Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort. In: Alimentary pharmacology & therapeutics, 2010, n° 8, p. 1007–1016. doi: 10.1111/j.1365-2036.2010.04434.x
Fichiers principaux (1)
Article
accessLevelRestricted
Identifiants
ISSN du journal0269-2813
542vues
0téléchargements

Informations techniques

Création23.05.2012 08:54:32
Première validation23.05.2012 08:54:32
Heure de mise à jour14.03.2023 17:35:08
Changement de statut14.03.2023 17:35:07
Dernière indexation12.02.2024 20:17:46
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack